Patient Guide: Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 32 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04278768
Status: 🟢 Enrolling Now
Condition: Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Phase: PHASE1, PHASE2

Where You Can Participate

This study is available at 32 locations across the country.

Top locations include:
  • • Tampa, Florida
  • • Atlanta, Georgia
  • • Chicago, Illinois
  • • And 29 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) - Join Clinical Trial NCTNCT04278768

How to Join This Clinical Trial - NCTNCT04278768

Learn how to participate in this PHASE1, PHASE2 trial studying an investigational therapy for Acute Myelogenous Leukemia, Myelodysplastic Syndrome. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Acute Myelogenous Leukemia, Myelodysplastic Syndrome. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Acute Myelogenous Leukemia, Myelodysplastic Syndrome
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1, PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04278768 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 32 locations. Find a study site near you:

Clinical Research Site

Tampa, Florida 33612 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Atlanta, Georgia 30322 - United States

Status: COMPLETED

Clinical Research Site

Chicago, Illinois 60611 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Chicago, Illinois 60637 - United States

Status: COMPLETED

Clinical Research Site

Boston, Massachusetts 02215 - United States

Status: RECRUITING

Clinical Research Site

Detroit, Michigan 48201 - United States

Status: COMPLETED

Clinical Research Site

Omaha, Nebraska 68130 - United States

Status: COMPLETED

Clinical Research Site

Bronx, New York 10461 - United States

Status: ACTIVE_NOT_RECRUITING

Clinical Research Site

Rochester, New York 14642 - United States

Status: COMPLETED

Clinical Research Site

Winston-Salem, North Carolina 27103 - United States

Status: COMPLETED

And 22 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1, PHASE2 clinical trial for Acute Myelogenous Leukemia, Myelodysplastic Syndrome:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships